BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

680 related articles for article (PubMed ID: 27998825)

  • 41. Augmented atherogenesis in LDL receptor deficient mice lacking both macrophage ABCA1 and ApoE.
    Lammers B; Zhao Y; Hoekstra M; Hildebrand RB; Ye D; Meurs I; Van Berkel TJ; Van Eck M
    PLoS One; 2011; 6(10):e26095. PubMed ID: 22022523
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Induction of inducible nitric oxide synthase (iNOS) expression by oxLDL inhibits macrophage derived foam cell migration.
    Huang H; Koelle P; Fendler M; Schröttle A; Czihal M; Hoffmann U; Conrad M; Kuhlencordt PJ
    Atherosclerosis; 2014 Jul; 235(1):213-22. PubMed ID: 24858340
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of bone marrow-derived CC-chemokine receptor 5 in the development of atherosclerosis of low-density lipoprotein receptor knockout mice.
    Potteaux S; Combadière C; Esposito B; Lecureuil C; Ait-Oufella H; Merval R; Ardouin P; Tedgui A; Mallat Z
    Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1858-63. PubMed ID: 16763157
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The capacity of group V sPLA2 to increase atherogenicity of ApoE-/- and LDLR-/- mouse LDL in vitro predicts its atherogenic role in vivo.
    Boyanovsky B; Zack M; Forrest K; Webb NR
    Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):532-8. PubMed ID: 19164803
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Targeted invalidation of SR-B1 in macrophages reduces macrophage apoptosis and accelerates atherosclerosis.
    Galle-Treger L; Moreau M; Ballaire R; Poupel L; Huby T; Sasso E; Troise F; Poti F; Lesnik P; Le Goff W; Gautier EL; Huby T
    Cardiovasc Res; 2020 Mar; 116(3):554-565. PubMed ID: 31119270
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Leukocyte Overexpression of Intracellular NAMPT Attenuates Atherosclerosis by Regulating PPARγ-Dependent Monocyte Differentiation and Function.
    Bermudez B; Dahl TB; Medina I; Groeneweg M; Holm S; Montserrat-de la Paz S; Rousch M; Otten J; Herias V; Varela LM; Ranheim T; Yndestad A; Ortega-Gomez A; Abia R; Nagy L; Aukrust P; Muriana FJG; Halvorsen B; Biessen EAL
    Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1157-1167. PubMed ID: 28408371
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CalDAG-GEFI Deficiency Reduces Atherosclerotic Lesion Development in Mice.
    Boulaftali Y; Owens AP; Beale A; Piatt R; Casari C; Lee RH; Conley PB; Paul DS; Mackman N; Bergmeier W
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):792-9. PubMed ID: 26988592
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mif-deficiency favors an atheroprotective autoantibody phenotype in atherosclerosis.
    Schmitz C; Noels H; El Bounkari O; Straussfeld E; Megens RTA; Sternkopf M; Alampour-Rajabi S; Krammer C; Tilstam PV; Gerdes N; Bürger C; Kapurniotu A; Bucala R; Jankowski J; Weber C; Bernhagen J
    FASEB J; 2018 Aug; 32(8):4428-4443. PubMed ID: 29543531
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rapamycin and FTY720 Alleviate Atherosclerosis by Cross Talk of Macrophage Polarization and Autophagy.
    Sun RZ; Fan Y; Liang X; Gong TT; Wang Q; Liu H; Shan ZY; Lei L
    Biomed Res Int; 2018; 2018():1010248. PubMed ID: 30627532
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Critical role of macrophage 12/15-lipoxygenase for atherosclerosis in apolipoprotein E-deficient mice.
    Huo Y; Zhao L; Hyman MC; Shashkin P; Harry BL; Burcin T; Forlow SB; Stark MA; Smith DF; Clarke S; Srinivasan S; Hedrick CC; Praticò D; Witztum JL; Nadler JL; Funk CD; Ley K
    Circulation; 2004 Oct; 110(14):2024-31. PubMed ID: 15451785
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Severe hyperhomocysteinemia promotes bone marrow-derived and resident inflammatory monocyte differentiation and atherosclerosis in LDLr/CBS-deficient mice.
    Zhang D; Fang P; Jiang X; Nelson J; Moore JK; Kruger WD; Berretta RM; Houser SR; Yang X; Wang H
    Circ Res; 2012 Jun; 111(1):37-49. PubMed ID: 22628578
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Deletion of haematopoietic Dectin-2 or CARD9 does not protect from atherosclerosis development under hyperglycaemic conditions.
    Thiem K; Hoeke G; Zhou E; Hijmans A; Houben T; Boels MG; Mol IM; Lutgens E; Shiri-Sverdlov R; Bussink J; Kanneganti TD; Boon MR; Stienstra R; Tack CJ; Rensen PC; Netea MG; Berbée JF; van Diepen JA
    Diab Vasc Dis Res; 2020; 17(1):1479164119892140. PubMed ID: 31868000
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Macrophage sphingomyelin synthase 2 deficiency decreases atherosclerosis in mice.
    Liu J; Huan C; Chakraborty M; Zhang H; Lu D; Kuo MS; Cao G; Jiang XC
    Circ Res; 2009 Jul; 105(3):295-303. PubMed ID: 19590047
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bone marrow-specific caspase-1/11 deficiency inhibits atherosclerosis development in Ldlr(-/-) mice.
    Hendrikx T; Jeurissen ML; van Gorp PJ; Gijbels MJ; Walenbergh SM; Houben T; van Gorp R; Pöttgens CC; Stienstra R; Netea MG; Hofker MH; Donners MM; Shiri-Sverdlov R
    FEBS J; 2015 Jun; 282(12):2327-38. PubMed ID: 25817537
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rho-associated coiled-coil-containing kinase 2 deficiency in bone marrow-derived cells leads to increased cholesterol efflux and decreased atherosclerosis.
    Zhou Q; Mei Y; Shoji T; Han X; Kaminski K; Oh GT; Ongusaha PP; Zhang K; Schmitt H; Moser M; Bode C; Liao JK
    Circulation; 2012 Oct; 126(18):2236-47. PubMed ID: 23011471
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prolactin receptor antagonism uncouples lipids from atherosclerosis susceptibility.
    van der Sluis RJ; van den Aardweg T; Reuwer AQ; Twickler MT; Boutillon F; Van Eck M; Goffin V; Hoekstra M
    J Endocrinol; 2014 Sep; 222(3):341-50. PubMed ID: 25063756
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Alteration of volume-regulated chloride channel during macrophage-derived foam cell formation in atherosclerosis.
    Hong L; Xie ZZ; Du YH; Tang YB; Tao J; Lv XF; Zhou JG; Guan YY
    Atherosclerosis; 2011 May; 216(1):59-66. PubMed ID: 21338988
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Trem2 Agonist Reprograms Foamy Macrophages to Promote Atherosclerotic Plaque Stability-Brief Report.
    Patterson MT; Xu Y; Hillman H; Osinski V; Schrank PR; Kennedy AE; Barrow F; Zhu A; Tollison S; Shekhar S; Stromnes IM; Tassi I; Wu D; Revelo XS; Binstadt BA; Williams JW
    Arterioscler Thromb Vasc Biol; 2024 Jul; 44(7):1646-1657. PubMed ID: 38695172
    [TBL] [Abstract][Full Text] [Related]  

  • 59. LPCAT3 deficiency in hematopoietic cells alters cholesterol and phospholipid homeostasis and promotes atherosclerosis.
    Thomas C; Jalil A; Magnani C; Ishibashi M; Queré R; Bourgeois T; Bergas V; Ménégaut L; Patoli D; Le Guern N; Labbé J; Gautier T; de Barros JPP; Lagrost L; Masson D
    Atherosclerosis; 2018 Aug; 275():409-418. PubMed ID: 29866392
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Matrix-metalloproteinase-14 deficiency in bone-marrow-derived cells promotes collagen accumulation in mouse atherosclerotic plaques.
    Schneider F; Sukhova GK; Aikawa M; Canner J; Gerdes N; Tang SM; Shi GP; Apte SS; Libby P
    Circulation; 2008 Feb; 117(7):931-9. PubMed ID: 18250269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.